ABSTRACT: Aplastic anemia (AA) is a rare, life-threatening disease characterized by pancytopenia and bone marrow failure. However, since the introduction of immunosuppressive therapy and allogeneic ...

Venetoclax is under clinical development by AbbVie and currently in Phase II for Aplastic Anemia. According to GlobalData, Phase II drugs for Aplastic Anemia have a 67% phase transition success rate ...

A 14-year-old patient presented to the ED with a 12-month history of joint pains and a 2-month history of headaches and ...

1,3,5,9-12 Pancytopenia, aplastic anemia neutropenia, thrombocytopenia Occasional case reports of severe cytopenias, with largely asymptomatic neutropenia in some series. 10,13-17 Demyelinating ...